Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.

Zhang D, Zaugg K, Mak TW, Elledge SJ.

Cell. 2006 Aug 11;126(3):529-42.

2.

MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, Alt FW, Chen J.

Mol Cell. 2006 Jan 20;21(2):187-200.

3.

Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.

Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, Livingston DM.

Genes Dev. 2006 Jan 1;20(1):34-46.

5.

Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.

Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD, Wang ZQ, Jasin M.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1110-5. Epub 2005 Jan 13.

6.

Interactions between BRCT repeats and phosphoproteins: tangled up in two.

Glover JN, Williams RS, Lee MS.

Trends Biochem Sci. 2004 Nov;29(11):579-85. Review.

PMID:
15501676
8.

BRCA1 and BRCA2: 1994 and beyond.

Narod SA, Foulkes WD.

Nat Rev Cancer. 2004 Sep;4(9):665-76. Review.

PMID:
15343273
9.

Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research.

Everley PA, Krijgsveld J, Zetter BR, Gygi SP.

Mol Cell Proteomics. 2004 Jul;3(7):729-35. Epub 2004 Apr 21.

10.

Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Rodriguez M, Yu X, Chen J, Songyang Z.

J Biol Chem. 2003 Dec 26;278(52):52914-8. Epub 2003 Oct 24.

11.

The BRCT domain is a phospho-protein binding domain.

Yu X, Chini CC, He M, Mer G, Chen J.

Science. 2003 Oct 24;302(5645):639-42.

12.

BRCT repeats as phosphopeptide-binding modules involved in protein targeting.

Manke IA, Lowery DM, Nguyen A, Yaffe MB.

Science. 2003 Oct 24;302(5645):636-9.

13.

Mass spectrometric-based approaches in quantitative proteomics.

Ong SE, Foster LJ, Mann M.

Methods. 2003 Feb;29(2):124-30. Review.

PMID:
12606218
14.

RAP80, a novel nuclear protein that interacts with the retinoid-related testis-associated receptor.

Yan Z, Kim YS, Jetten AM.

J Biol Chem. 2002 Aug 30;277(35):32379-88. Epub 2002 Jun 21.

15.

Cancer susceptibility and the functions of BRCA1 and BRCA2.

Venkitaraman AR.

Cell. 2002 Jan 25;108(2):171-82. Review.

16.

Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.

Xu B, Kim ST, Lim DS, Kastan MB.

Mol Cell Biol. 2002 Feb;22(4):1049-59.

17.

The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

Baer R, Ludwig T.

Curr Opin Genet Dev. 2002 Feb;12(1):86-91. Review.

PMID:
11790560
18.
19.

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM.

Cell. 2001 Apr 6;105(1):149-60.

20.

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.

Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T.

J Biol Chem. 2001 May 4;276(18):14537-40. Epub 2001 Mar 6.

Supplemental Content

Support Center